SCHEMBL417104

SCHEMBL417104

Cc1c(C(=O)O)ccc(C(F)(F)F)c1[S+](C)[O-]

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 2/20 0.40
NOTUM Q6P988 4/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
CES2 O00748 2/20 0.37
DHODH Q02127 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
DAO P14920 1/20 0.34
ASPH Q12797 1/20 0.34
TSHR P16473 1/20 0.34
SORT1 Q99523 2/20 0.34
USP2 O75604 1/20 0.34
CYP2C19 P33261 1/20 0.34
PTGER4 P35408 1/20 0.33
HAAO P46952 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30122985 0.83 CLCN2 (0.40) TAS2R14NOTUMRXRARXRBCES2
SCHEMBL9949591 0.81 TDP1 (0.39) TAS2R14NOTUMCES2KDM4EALDH1A1
SCHEMBL10053348 0.78 TAS2R14 (0.51) TAS2R14NOTUMRXRARXRBCES2
SCHEMBL27466963 0.75 TAS2R14 (0.45) TAS2R14NOTUMRXRARXRBCES2
SCHEMBL30634615 0.75 TAS2R14 (0.45) TAS2R14NOTUMRXRARXRBCES2
SCHEMBL1634606 0.75 TAS2R14 (0.45) TAS2R14NOTUMRXRARXRBCES2
SCHEMBL10053356 0.75
SCHEMBL9949885 0.75 AR (0.31)
SCHEMBL10053358 0.74 NR3C1 (0.31)
SCHEMBL29489588 0.74 NPC1 (0.41) TSHRSORT1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2658841-B1 PROCESS FOR PREPARING 3-ALKYLSULFINYLBENZOYL DERIVATIVES BAYER IP GMBH (DE) 2017-09-20 EP disclosed
CN-103534234-B The preparation method of 3-alkylsulfinylbenzoyl derivant 拜耳知识产权有限责任公司 2016-09-14 CN disclosed
EP-2595954-B1 (4-TRIFLUORMETHYL-3-THIOBENZOYL)CYCLOHEXANEDIONES AND USE THEREOF AS HERBICIDES BAYER IP GMBH (DE) 2016-05-04 EP disclosed
CN-103119020-B (4-trifluoromethyl-3-thiobenzoyl) cyclohexanedione and the purposes as weedicide thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-08-12 CN disclosed
CN-103534234-A Process for preparing 3-alkylsulfinylbenzoyl derivatives BAYER IP GMBH 2014-01-22 CN disclosed
EP-2658841-A1 PROCESS FOR PREPARING 3-ALKYLSULFINYLBENZOYL DERIVATIVES Bayer Intellectual Property GmbH (DE) 2013-11-06 EP disclosed
US-8563779-B2 (4-trifluoromethyl-3-thiobenzoyl)cyclohexanediones and use thereof as herbicides BAYER CROPSCIENCE AG (DE) 2013-10-22 US disclosed
US-8455657-B2 Process for the preparation of 3-alkylsulfinylbenzoyl derivatives BAYER CROPSCIENCE AG (DE) 2013-06-04 US disclosed
EP-2595954-A1 (4-TRIFLUORMETHYL-3-THIOBENZOYL)CYCLOHEXANEDIONES AND USE THEREOF AS HERBICIDES Bayer Intellectual Property GmbH (DE) 2013-05-29 EP disclosed
CN-103119020-A (4-trifluormethyl-3-thiobenzoyl) cyclohexanediones and use thereof as herbicides BAYER CROPSCIENCE AG 2013-05-22 CN disclosed
WO-2012089644-A1 PROCESS FOR PREPARING 3-ALKYLSULFINYLBENZOYL DERIVATIVES BAYER CROPSCIENCE AG (DE) 2012-07-05 WO disclosed
US-20120165540-A1 PROCESS FOR THE PREPARATION OF 3-ALKYLSULFINYLBENZOYL DERIVATIVES BAYER CROPSCIENCE AG (DE) 2012-06-28 US disclosed
US-20120021902-A1 (4-TRIFLUOROMETHYL-3-THIOBENZOYL)CYCLOHEXANEDIONES AND USE THEREOF AS HERBICIDES BAYER CROPSCIENCE AG (DE) 2012-01-26 US disclosed
WO-2012010574-A1 (4-TRIFLUORMETHYL-3-THIOBENZOYL)CYCLOHEXANEDIONES AND USE THEREOF AS HERBICIDES BAYER CROPSCIENCE AG (DE) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165540-A1 PROCESS FOR THE PREPARATION OF 3-ALKYLSULFINYLBENZOYL DERIVATIVES CBR3, CBR1, CYP1B1 TAS2R14 1961/4885NOTUM 2324/4885RXRA 1505/4885
US-20120021902-A1 (4-TRIFLUOROMETHYL-3-THIOBENZOYL)CYCLOHEXANEDIONES AND USE THEREOF AS HERBICIDES CBR3, DDT, CYP4X1 TAS2R14 1358/4885NOTUM 1045/4885RXRA 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.